Board of Directors Meeting: February 2, 2023

Minutes

Directors Present: Bill Hatanaka (Chair), Elyse Allan (Vice Chair), Jay Aspin, Alex Barron, Jean-Robert Bernier, Adalsteinn Brown, Lynda Hawton Kitamura (via videoconference), Gillian Kernaghan, Jackie Moss, Paul Tsaparis, Anju Virmani

Directors not in Attendance: N/A

Ontario Health: Matthew Anderson (Chief Executive Officer), Anne Corbett (General Counsel and Executive Lead, Legal, Privacy and Risk), Ashley Potts (Program Manager, Legal, Privacy, Risk and Governance), Christine Gan (Executive Assistant, Legal, Risk, Privacy & Governance), Phuong Truong (Governance Coordinator), Louise Verity (Strategic Advisor, Office of the CEO), Judy Linton (Chief Nursing Officer – for item 7, via videoconference)

Invited Guest(s): N/A

1. Chair’s Opening Remarks

The Chair welcomed Board Members to the meeting.

The February 2, 2023 Board meeting is Ms. Virmani’s last Board meeting with Ontario Health before her appointment ends. Mr. Hatanaka thanked Ms. Virmani for her contributions to the Ontario Health Board.

1.1 Call to Order

The meeting was called to order at 12:25 p.m.

1.2 Recognition of Quorum

With quorum present, the meeting was formally constituted.

1.3 Declarations of Conflict

No conflicts of interest were declared.

1.4 Approve Agenda

Upon motion duly made, seconded, and unanimously carried, the Agenda was approved as presented.

1.5 Dedication – Anju Virmani

The February 2, 2023 Board meeting is Ms. Virmani’s last Board meeting with Ontario Health before her appointment ends. Ms. Virmani thanked the Board of Directors and Senior Leadership team for their dedication, advice, insights and hard work over the last four years.

Mr. Hatanaka will dedicate the next Board meeting.

1.7 Review Follow-Up Items

The Chair noted there were no follows-ups due in February.

Consent Agenda

2.1 Approve December 14, 2022 Board Minutes

Upon motion duly made, seconded, and unanimously carried, the minutes of the December 14, 2022 Board meeting were approved.

The Board moved to a closed session due to the discussion of topics that are or may be subject to exemptions under the Freedom of Information and Protection of Privacy Act.

The Board returned to an open session.

6. Governance and Nominating Committee (GNC) Report

The Committee Chair reported on the February 1, 2023 meeting, including:

  • Board and Committee Meeting Schedule

The Board moved to a closed session due to the discussion of topics that are or may be subject to exemptions under the Freedom of Information and Protection of Privacy Act.

The Board returned to an open session.

7. Quality Committee (QC) Report

The Committee Chair reported on the February 1, 2023 meeting, including:

  • Management Update

The Board moved to a closed session due to the discussion of topics that are or may be subject to exemptions under the Freedom of Information and Protection of Privacy Act.

The Board returned to an open session.

8. Human Resources and Compensation Committee (HRCC) Report

The Committee Chair reported on the February 2,2023 meeting, including:

  • OH Equity, Inclusion, Diversity & Anti-Racism Quarterly Update

The Board moved to a closed session due to the discussion of topics that are or may be subject to exemptions under the Freedom of Information and Protection of Privacy Act.

Termination of meeting

The meeting was adjourned at 5:00 p.m.

Upon motion duly made, seconded and unanimously carried the meeting was adjourned.

(Original signed by)
William Hatanaka, Board Chair

(Original signed by)
Anne Corbett, Corporate Secretary

Last Updated: October 23, 2024